The IPO window doesn't appear to be opening anytime soon, but life sciences lawyers expect mergers—and regulatory challenges—to pick up this year.
January 27, 2023 at 02:54 PM
5 minute read
In lieu of a rapid IPO bounce back, life sciences lawyers anticipate alternative financings and combinations to pick up in 2023, along with continued momentum for regulatory expertise.
Lawyers who attended the JP Morgan Healthcare Conference in San Francisco earlier this month said the general mood of life sciences stakeholders ranged from “guardedly neutral” to “settled.”
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
(Credit: Yurchanka Siarhei/Shutterstock)
